BioSpace News Archive

Ultragenyx Pharmaceutical Inc. reported the grant of non-qualified stock options to purchase an aggregate of 16,050 shares of common stock of the company and 5,350 restricted stock units of the company’s common stock to two newly hired non-executive officers of the company.

Adaptive Biotechnologies Corporation announced it will be participating in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

Viking Therapeutics, Inc. announced today that the company will release financial results for the fourth quarter and year-end 2021, after the market close on Wednesday, February 9, 2022.

Exelixis, Inc. announced that company management will participate in a fireside chat at the virtual Guggenheim Healthcare Talks Oncology Day on Wednesday, February 9, 2022 at 1:30pm ET / 10:30am PT.

Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal first quarter ended December 25, 2021.

Vicarious Surgical Inc. announced the company will participate in a fireside chat at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

NeoGenomics, Inc. announced today that it plans to release its fourth quarter 2021, financial results on Wednesday, February 23, 2022.

ORIC Pharmaceuticals, Inc., a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, announced that management will participate in a virtual fireside chat at the Guggenheim 2022 Oncology Conference on Thursday, February 10, 2022, at 2:00 p.m. ET.

SomaLogic, Inc., a leader in AI-data driven proteomics technology, announced that the company will be participating in the following virtual investor conferences.

Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Nicole LaBrosse has been promoted to the position of senior vice president, chief financial officer, effective immediately.